CRT 2025

Early Feasibility Studies Structural

Longer-Term Outcomes with AMEND Mitral Annuloplasty | First-in-Human Cohort

Speaker(s)

• 

  Paul Sorajja, MD

  Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital
  Allina Health Minneapolis Heart Institute
  Minneapolis, Minnesota, United States

  Disclosure(s): LAZA: Consulting Fees (e.g., advisory boards) (Ongoing)